Erratum: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma (Oncotarget (2017) 8 (65186-65198) DOI:10.18632/oncotarget.18053)

Suliman Boulos; Min Chul Park; Marian Zeibak; Shen Yun Foo; Yoon Kyung Jeon; Young Tae Kim; Alex Motzik; Sagi Tshori; Tamar Hamburger; Sunghoon Kim; Hovav Nechushtan; Ehud Razin

Erratum: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma (Oncotarget (2017) 8 (65186-65198) DOI:10.18632/oncotarget.18053)

Suliman Boulos
, Min Chul Park
, Marian Zeibak
, Shen Yun Foo
, Yoon Kyung Jeon
, Young Tae Kim
, Alex Motzik
, Sagi Tshori
, Tamar Hamburger
, Sunghoon Kim
, Hovav Nechushtan
, Ehud Razin

Institute for Medical Research Israel-Canada (IMRIC)

Research output: Contribution to journal › Comment/debate

Abstract

Figure 5: Subgroup analysis of nuclear P207 LysRS according to Lymph nodes positivity. Disease free survival of wild-type EGFR patients with (positive) or without (negative) cytosolic (A) and nuclear (B) LysRS. Disease free survival of mutated EGFR patients with (positive) or without (negative) cytosolic (C) and nuclear (D) LysRS.

Original language	English
Pages (from-to)	36250
Number of pages	1
Journal	Oncotarget
Volume	9
Issue number	90
State	Published - 1 Nov 2018

Bibliographical note

Publisher Copyright:
Copyright: Boulos et al.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Boulos, S., Park, M. C., Zeibak, M., Foo, S. Y., Jeon, Y. K., Kim, Y. T., Motzik, A., Tshori, S., Hamburger, T., Kim, S., Nechushtan, H., & Razin, E. (2018). Erratum: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma (Oncotarget (2017) 8 (65186-65198) DOI:10.18632/oncotarget.18053). Oncotarget, 9(90), 36250.

@article{7a3e28d889dc418cb64a8e22040cce50,

title = "Erratum: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma (Oncotarget (2017) 8 (65186-65198) DOI:10.18632/oncotarget.18053)",

abstract = "Figure 5: Subgroup analysis of nuclear P207 LysRS according to Lymph nodes positivity. Disease free survival of wild-type EGFR patients with (positive) or without (negative) cytosolic (A) and nuclear (B) LysRS. Disease free survival of mutated EGFR patients with (positive) or without (negative) cytosolic (C) and nuclear (D) LysRS.",

author = "Suliman Boulos and Park, \{Min Chul\} and Marian Zeibak and Foo, \{Shen Yun\} and Jeon, \{Yoon Kyung\} and Kim, \{Young Tae\} and Alex Motzik and Sagi Tshori and Tamar Hamburger and Sunghoon Kim and Hovav Nechushtan and Ehud Razin",

note = "Publisher Copyright: Copyright: Boulos et al.",

year = "2018",

month = nov,

day = "1",

language = "אנגלית",

volume = "9",

pages = "36250",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "90",

}

TY - JOUR

T1 - Erratum

T2 - Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma (Oncotarget (2017) 8 (65186-65198) DOI:10.18632/oncotarget.18053)

AU - Boulos, Suliman

AU - Park, Min Chul

AU - Zeibak, Marian

AU - Foo, Shen Yun

AU - Jeon, Yoon Kyung

AU - Kim, Young Tae

AU - Motzik, Alex

AU - Tshori, Sagi

AU - Hamburger, Tamar

AU - Kim, Sunghoon

AU - Nechushtan, Hovav

AU - Razin, Ehud

N1 - Publisher Copyright: Copyright: Boulos et al.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Figure 5: Subgroup analysis of nuclear P207 LysRS according to Lymph nodes positivity. Disease free survival of wild-type EGFR patients with (positive) or without (negative) cytosolic (A) and nuclear (B) LysRS. Disease free survival of mutated EGFR patients with (positive) or without (negative) cytosolic (C) and nuclear (D) LysRS.

AB - Figure 5: Subgroup analysis of nuclear P207 LysRS according to Lymph nodes positivity. Disease free survival of wild-type EGFR patients with (positive) or without (negative) cytosolic (A) and nuclear (B) LysRS. Disease free survival of mutated EGFR patients with (positive) or without (negative) cytosolic (C) and nuclear (D) LysRS.

UR - https://www.scopus.com/pages/publications/85056994589

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 30546840

AN - SCOPUS:85056994589

SN - 1949-2553

VL - 9

SP - 36250

JO - Oncotarget

JF - Oncotarget

IS - 90

ER -

Erratum: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma (Oncotarget (2017) 8 (65186-65198) DOI:10.18632/oncotarget.18053)

Abstract

Bibliographical note

UN SDGs

Other files and links

Fingerprint

Cite this